PHP
ARWR icon

Parkman Healthcare Partners’s Arrowhead Research ARWR Stock Holding History

Parkman Healthcare Partners’s Portfolio ARWR Stock Details ARWR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-70,089
Closed -$4.65M – 84
2021
Q1 		$4.65M Sell
70,089
-57,082
-45% -$4.43M 1.08% 30
2020
Q4 		$9.76M Buy
127,171
+67,171
+112% +$4.3M 2.5% 11
2020
Q3 		$2.58M Buy
+60,000
New +$2.59M 0.68% 51

Other funds holding ARWR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parkman Healthcare Partners's ARWR Position: Q2 2021 in Review

Parkman Healthcare Partners sold out of Arrowhead Research (ARWR) in Q2 2021, closing a stake of 70,089 shares — an estimated $4.65M sold.

Parkman Healthcare Partners first reported a position in ARWR in Q3 2020 and held it in 3 quarters. The position peaked at $9.76M in Q4 2020. 314 funds tracked by Wall St. Rank hold ARWR as of Q2 2021.

  • Parkman Healthcare Partners reported no remaining Arrowhead Research position as of Q2 2021 after selling out during the quarter.
  • Parkman Healthcare Partners sold 70,089 Arrowhead Research shares in Q2 2021, an estimated $4.65M.
  • Parkman Healthcare Partners first reported a position in Arrowhead Research in Q3 2020 and held it in 3 quarters.
  • Parkman Healthcare Partners's Arrowhead Research position peaked at $9.76M in Q4 2020.
  • 314 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2021.

Based on Parkman Healthcare Partners's 13F filing for Q2 2021, filed 13 Aug 2021.